SS
DYN icon

Steve Schonfeld’s Dyne Therapeutics DYN Stock Holding History

Steve Schonfeld’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.99M Buy
+134,752
New +$2.51M 0.01% 865
2025
Q4 		– Sell
-415,927
Closed -$5.26M – 2177
2025
Q3 		$5.26M Buy
415,927
+82,474
+25% +$941K 0.03% 565
2025
Q2 		$3.17M Buy
333,453
+187,159
+128% +$2.06M 0.02% 757
2025
Q1 		$1.53M Buy
+146,294
New +$2.09M 0.01% 1087
2024
Q4 		– Sell
-36,352
Closed -$1.31M – 2100
2024
Q3 		$1.31M Sell
36,352
-78,843
-68% -$3.14M 0.01% 1066
2024
Q2 		$4.07M Sell
115,195
-154,562
-57% -$4.49M 0.03% 623
2024
Q1 		$7.66M Sell
269,757
-5,942
-2% -$134K 0.05% 474
2023
Q4 		$3.67M Buy
+275,699
New +$2.69M 0.02% 600

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Steve Schonfeld's DYN Position: Q2 2026 in Review

Steve Schonfeld opened a new position in Dyne Therapeutics (DYN) in Q2 2026: 134,752 shares worth $2.99M. The stake represents 0.01% of the portfolio and ranks #865 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in DYN as recently as Q3 2025.

Steve Schonfeld first reported a position in DYN in Q4 2023 and has held it in 8 quarters since. The position peaked at $7.66M in Q1 2024. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Steve Schonfeld held 134,752 shares of Dyne Therapeutics worth $2.99M as of Q2 2026.
  • Dyne Therapeutics was a new Steve Schonfeld position in Q2 2026.
  • Dyne Therapeutics made up 0.01% of Steve Schonfeld's portfolio in Q2 2026, its #865 holding.
  • Steve Schonfeld first reported a position in Dyne Therapeutics in Q4 2023 and has held it in 8 quarters since.
  • Steve Schonfeld's Dyne Therapeutics position peaked at $7.66M in Q1 2024.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.